NIIMBL spends $4.6M to fund biopharmaceutical projects

By The Science Advisory Board staff writers

June 9, 2021 -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is spending $4.6 million to fund 10 new biopharmaceutical manufacturing projects.

The projects were selected from the institute's Project Call 4.1. The projects aim to drive innovation and advancement in the areas of cell and gene therapy manufacturing and vaccine stabilization.

The following projects were selected:

  • A fully continuous downstream process for high-titer products, which is being led by Rensselaer Polytechnic Institute
  • A multifunctional microfluidic chip for rapid vector genome and empty capsid, which is being led by North Carolina State University
  • A system for rapid testing bioburden or sterility with automated imaging, which is being led by Mango
  • Development of a fluorescence-based continuous anion-exchange high-performance liquid chromatography (AEX-HPLC) method for quantification of full, partial, and empty capsids in adeno-associated viral vector products, which is being led by the University of Massachusetts Lowell
  • Novel wicking bioreactor for T-cell expansion, which is being led by Sepragen
  • Bioprocess online training using digital twin, which is being led by Keck Graduate Institute
  • Modularized portable alliance testing online training platform to accelerate workforce innovation in biopharmaceuticals manufacturing, which is being led by Northeastern University
  • Biomanufacturing consortium for analytics and data engineering expansion, which is being led by Santa Clara University
  • Tunable radio frequency/microwave drying of biologics, which is being led by Purdue University
  • A commercial-scale, aseptic spray freeze dryer, which is being led by IMA Life North America

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here